Glucocorticoid Dose in COVID-19: Lessons for Clinical Trials During a Pandemic

JAMA. 2021 Nov 9;326(18):1801-1802. doi: 10.1001/jama.2021.16438.

Authors

Steven A Webb^{1

2}, Alisa M Higgins¹, Colin J McArthur³

Affiliations

¹ Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
² St John of God Hospital, Subiaco, Australia.
³ Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand.

PMID: 34673891
DOI: 10.1001/jama.2021.16438

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Glucocorticoids
Humans
Pandemics* / prevention & control
SARS-CoV-2

Substances

Glucocorticoids